Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow ELV
Elevance Health, Inc. (ELV) Return on invested capital
Elevance Health, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 11.8%, down 0.9 percentage points from fiscal 2025 (12.7%). Over the past ten years it has ranged from 12.7% (fiscal 2025) to 21.3% (fiscal 2021) — the current reading is the lowest in ten years. That is above the Healthcare Plans industry median of 2.04% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 12.7% | (2.36) |
| FY2024 | 15.1% | (4.47) |
| FY2023 | 19.6% | (0.83) |
| FY2022 | 20.4% | (0.91) |
| FY2021 | 21.3% | 1.71 |
| FY2020 | 19.6% | 3.09 |
| FY2019 | 16.5% | 1.24 |
| FY2018 | 15.3% | (0.23) |
| FY2017 | 15.5% | (4.39) |
| FY2016 | 19.9% | 0.00 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| HUM Humana Inc. compare | 17.5% |
| ELV Elevance Health, Inc. | 11.8% |
| UNH UnitedHealth Group Incorporated compare | 10.4% |
| CI Cigna Group compare | 9.09% |
| CVS CVS Health Corporation compare | 4.07% |
| OSCR Oscar Health, Inc. compare | 0.00% |
| MOH Molina Healthcare, Inc compare | 0.00% |
| CLOV Clover Health Investments, Corp. compare | −8.62% |
| CNC Centene Corporation compare | −30.2% |
| Healthcare Plans industry median | 2.04% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement